Lapsed Apr 17, 2026 on the fee record · High confidence
20-year base term ends May 21, 2028
Second maintenance fee unpaid; grace period ended.
May 21, 2008
Apr 17, 2026
Apr 17, 2018
May 21, 2028
Its term would have run to May 21, 2028: its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 21, 2008, when application PCT/US2008/064417, the earliest non-provisional in its chain, was filed (this one was filed Feb 22, 2016) | May 21, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,314,227, US 9,051,570, US 9,297,009) | resolves to May 21, 2028, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 2 maintenance fees paid | lapsed Apr 17, 2026 | High confidence |
| Computed term end | The steps above, in order | Apr 17, 2026 | High confidence |
This family
| US 8,314,227 | In force Sep 2028 | Sep 2028 |
| US 9,051,570 | In force Sep 2028 | Sep 2028 |
| US 9,303,260 | In force May 2028 | May 2028 |
| US 9,297,009 | In force May 2028 | May 2028 |
| US 9,944,929 | this patent Apr 2026 | Apr 2026 |
| US 10,457,945 | In force May 2028 | May 2028 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jun 24, 2019 Reel 49571, frame 542 | Wengel, Jesper | Ribotask APS | Assignment of Assignor's Interest |
| Jun 24, 2019 Reel 49571, frame 618 | Ribotask APS | Mdrna, Inc. | Assignment of Assignor's Interest |
| Jun 24, 2019 Reel 49571, frame 701 | Marina Biotech, Inc. | Arcturus Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jul 12, 2019 Reel 49746, frame 32 | Mdrna, Inc. | Marina Biotech, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 8,314,227, US 9,051,570, US 9,297,009, ends no earlier than this term, so it caps nothing.